Caseous stomatitis caused by Pseudomonas aeruginosa in Boa constrictor amarali

Background: Pseudomonas aeruginosa is a bacterium that belongs to the microbiota of snakes, but it may also be anopportunistic pathogen and contaminate humans through fecal contact, bites, and injuries. In snakes, this microorganismmay present high pathogenicity at certain conditions and have been associated with high morbidity and mortality. Reportsof infection of Boa constrictor by this pathogen are rare. Thus, this study aimed to describe the P. aeruginosa oral infection in a snake specimen (Boa constrictor amarali), approaching the isolation and identification of the infectious agentsinvolved, the antimicrobial sensitivity and resistance, and the therapeutic protocol adopted.Case: A free-living adult female specimen of Boa constrictor amarali (Amaral’s boa), with no described previous history was rescued in an urban area by the Environmental Police. Clinical evaluations showed structures of caseous aspectin the oral cavity, with hyperemia spots in the mucosa. Samples of these lesions were sent for mycological examination,and fungal forms were not found. Samples were collected for isolation and culture. The antimicrobial susceptibility of theisolated microorganisms was determined by the modified Kirby-Bauer disk diffusion method. P. aeruginosa was isolatedand showed susceptibility to amikacin, gentamicin, and polymyxin-B; intermediate susceptibility to azithromycin, and ciprofloxacin; and resistance to cephalexin, ceftiofur, chloramphenicol, and enrofloxacin. The treatment consisted of cleaningof the oral cavity, local infiltration of lidocaine for debridement of the caseous area that were later cauterized with iodine.Systemic antibiotic therapy was used, with intramuscular administration of amikacin (5 mg/kg) for the first dose and (2.5mg/kg) for the other doses with intervals of 72 h, and oral administration of metronidazole...

Caseous stomatitis caused by Pseudomonas aeruginosa in Boa constrictor amarali

Background: Pseudomonas aeruginosa is a bacterium that belongs to the microbiota of snakes, but it may also be anopportunistic pathogen and contaminate humans through fecal contact, bites, and injuries. In snakes, this microorganismmay present high pathogenicity at certain conditions and have been associated with high morbidity and mortality. Reportsof infection of Boa constrictor by this pathogen are rare. Thus, this study aimed to describe the P. aeruginosa oral infection in a snake specimen (Boa constrictor amarali), approaching the isolation and identification of the infectious agentsinvolved, the antimicrobial sensitivity and resistance, and the therapeutic protocol adopted.Case: A free-living adult female specimen of Boa constrictor amarali (Amarals boa), with no described previous history was rescued in an urban area by the Environmental Police. Clinical evaluations showed structures of caseous aspectin the oral cavity, with hyperemia spots in the mucosa. Samples of these lesions were sent for mycological examination,and fungal forms were not found. Samples were collected for isolation and culture. The antimicrobial susceptibility of theisolated microorganisms was determined by the modified Kirby-Bauer disk diffusion method. P. aeruginosa was isolatedand showed susceptibility to amikacin, gentamicin, and polymyxin-B; intermediate susceptibility to azithromycin, and ciprofloxacin; and resistance to cephalexin, ceftiofur, chloramphenicol, and enrofloxacin. The treatment consisted of cleaningof the oral cavity, local infiltration of lidocaine for debridement of the caseous area that were later cauterized with iodine.Systemic antibiotic therapy was used, with intramuscular administration of amikacin (5 mg/kg) for the first dose and (2.5mg/kg) for the other doses with intervals of 72 h, and oral administration of metronidazole...(AU)

Systemic infection by methicillin-resistant Staphylococcus pseudintermedius in a bitch

Background: Staphylococcus pseudintermedius is an opportunistic pathogen, belonging to the genus Staphylococcus.The methicillin-resistant Staphylococci have the mecA-gene, which confers them with the ability of becoming resistant tomethicillin and multiple classes of antimicrobials, which makes the treatment of the affections caused by these specimensdifficult. This work describes a case of systemic infection and death by methicillin-resistant S. pseudintermedius, in a canine.Case: A crossbred bitch (Canis lupus familiaris), was admitted to the University Veterinary Hospital of the Federal Universityof Western Bahia (HVU-UFOB). The main complaint reported by the owner was the presence of mammary nodules andconstant nasal secretion. During the clinical examination was observed reactivity in the popliteal and left submandibularlymph nodes, pale mucous membranes, stomatitis, bilateral mucopurulent nasal secretion, abdominal pustules, serous secretion in the inguinal mammary gland and focal alopecia on the dorsum. On auscultation, was identified only arrhythmiaand the other physiological parameters of the animal were within normality for the species. Samples of the nasal secretionand of the secretion from the abdominal pustules were collected, and sent to the Veterinary Microbiology Laboratory ofthe same institution. The samples collected were sown in 5% Blood Agar (BA), Sabouraud Agar (SAB) and MacConkeyAgar (MCK), after 24 h was observed in BA the growth of macroscopically white colonies, with a humid aspect, creamyconsistency, with presence of catalase and α-hemolysis. Microscopically, was observed the presence of Gram-positivecocci, suggestive of Staphylococcus sp. Microscopically, was observed the presence of Gram-positive cocci, suggestiveof Staphylococcus sp. In the MALDI-TOF mass spectrometry, was identified S. pseudintermedius. Enrofloxacin [Enrotrat...

Systemic infection by methicillin-resistant Staphylococcus pseudintermedius in a bitch

Background: Staphylococcus pseudintermedius is an opportunistic pathogen, belonging to the genus Staphylococcus.The methicillin-resistant Staphylococci have the mecA-gene, which confers them with the ability of becoming resistant tomethicillin and multiple classes of antimicrobials, which makes the treatment of the affections caused by these specimensdifficult. This work describes a case of systemic infection and death by methicillin-resistant S. pseudintermedius, in a canine.Case: A crossbred bitch (Canis lupus familiaris), was admitted to the University Veterinary Hospital of the Federal Universityof Western Bahia (HVU-UFOB). The main complaint reported by the owner was the presence of mammary nodules andconstant nasal secretion. During the clinical examination was observed reactivity in the popliteal and left submandibularlymph nodes, pale mucous membranes, stomatitis, bilateral mucopurulent nasal secretion, abdominal pustules, serous secretion in the inguinal mammary gland and focal alopecia on the dorsum. On auscultation, was identified only arrhythmiaand the other physiological parameters of the animal were within normality for the species. Samples of the nasal secretionand of the secretion from the abdominal pustules were collected, and sent to the Veterinary Microbiology Laboratory ofthe same institution. The samples collected were sown in 5% Blood Agar (BA), Sabouraud Agar (SAB) and MacConkeyAgar (MCK), after 24 h was observed in BA the growth of macroscopically white colonies, with a humid aspect, creamyconsistency, with presence of catalase and α-hemolysis. Microscopically, was observed the presence of Gram-positivecocci, suggestive of Staphylococcus sp. Microscopically, was observed the presence of Gram-positive cocci, suggestiveof Staphylococcus sp. In the MALDI-TOF mass spectrometry, was identified S. pseudintermedius. Enrofloxacin [Enrotrat...(AU)

Antimicrobial susceptibility profile of historical and recent Brazilian pig isolates of Pasteurella multocida / Perfil de suscetibilidade a antimicrobianos de isolados históricos e contemporâneos de Pasteurella multocida de suínos no Brasil

Pasteurella (P.) multocida is the causative agent of pneumonic pasteurellosis in swine, which is commonly associated with the final stages of enzootic pneumonia or porcine respiratory disease complex. Although this syndrome is one of the most common and important diseases of pigs, data on antimicrobial susceptibility of P. multocida isolates are uncommon in Brazil. Therefore, the present study was carried out to determine and to compare antimicrobial susceptibility profile of Brazilian P. multocida isolated from pigs with lesions of pneumonia or pleuritis during two-time periods. Historical isolates (period of 1981 to 1997; n=44) and recent isolates (period of 2011 to 2012; n=50) were used to determine the MIC of amoxicillin, enrofloxacin, florfenicol and tetracycline by microbroth dilution. Florfenicol had the lowest level of resistance for both historical and recent isolates (0% and 6%, respectively), while tetracycline had the highest (20.5% and 34%, respectively). Multi-drug resistance (MDR) to amoxicillin/florfenicol/tetracycline was observed in 6% of recent isolates. There was a significant increase (p˂0.05) in resistance for amoxicillin and enrofloxacin in recent isolates compared with historic isolates (3.8% and 18%, respectively), most likely due to the selective pressure of antimicrobial usage to treat and prevent P. multocida infections. The results of this study showed an increase of isolates resistant to important drugs used in treatment of P. multocida infections in pigs, demonstrating the need for the implementation of rational use of antimicrobials in Brazilian swine industry.(AU)

Pasteurella (P.) multocida é o agente da pasteurelose pneumônica em suínos, a qual é comumente associada com o estágio final da pneumonia enzoótica suína ou complexo das doenças respiratórias dos suínos. Apesar de ser uma das doenças mais comuns e importantes na suinocultura, dados sobre suscetibilidade antimicrobiana de isolados de P. multocida são raros no Brasil. Dessa forma, o presente estudo foi realizado para determinar e comparar o perfil de suscetibilidade de isolados de P. multocida de suínos com lesões de pneumonia ou pleurite no Brasil durante dois períodos. Isolados históricos (período de 1981 a 1997; n=44) e contemporâneos (período de 2011 a 2012; n=50) foram usados para determinar a concentração inibitória mínima (CIM) de amoxicilina, enrofloxacina, florfenicol e tetraciclina através do teste de microdiluição em caldo. Florfenicol apresentou o menor nível de resistência para ambos os isolados históricos e contemporâneos (0% e 6%, respectivamente), enquanto que tetraciclina apresentou o maior nível de resistência (20.5% e 34%, respectivamente). Resistência a múltiplos antimicrobianos (amoxicilina, florfenicol e tetraciclina) foi observada em 6% dos isolados recentes. Foi observado aumento significativo (p˂0.05) na resistência a amoxicilina e enrofloxacina em isolados recentes comparado com isolados históricos (3.8% e 18%, respectivamente), provavelmente devido à pressão de seleção de antimicrobianos usados no tratamento e prevenção de infecções causadas por P. multocida. Os resultados deste trabalho demostraram o aumento de isolados resistentes a importantes drogas utilizadas no tratamento de infecções causadas por P. multocida em suínos, evidenciando a necessidade da implementação do uso racional de antimicrobianos na suinocultura brasileira.(AU)

Antimicrobial susceptibility profile of historical and recent Brazilian pig isolates of Pasteurella multocida / Perfil de suscetibilidade a antimicrobianos de isolados históricos e contemporâneos de Pasteurella multocida de suínos no Brasil

Pasteurella (P.) multocida is the causative agent of pneumonic pasteurellosis in swine, which is commonly associated with the final stages of enzootic pneumonia or porcine respiratory disease complex. Although this syndrome is one of the most common and important diseases of pigs, data on antimicrobial susceptibility of P. multocida isolates are uncommon in Brazil. Therefore, the present study was carried out to determine and to compare antimicrobial susceptibility profile of Brazilian P. multocida isolated from pigs with lesions of pneumonia or pleuritis during two-time periods. Historical isolates (period of 1981 to 1997; n=44) and recent isolates (period of 2011 to 2012; n=50) were used to determine the MIC of amoxicillin, enrofloxacin, florfenicol and tetracycline by microbroth dilution. Florfenicol had the lowest level of resistance for both historical and recent isolates (0% and 6%, respectively), while tetracycline had the highest (20.5% and 34%, respectively). Multi-drug resistance (MDR) to amoxicillin/florfenicol/tetracycline was observed in 6% of recent isolates. There was a significant increase (p˂0.05) in resistance for amoxicillin and enrofloxacin in recent isolates compared with historic isolates (3.8% and 18%, respectively), most likely due to the selective pressure of antimicrobial usage to treat and prevent P. multocida infections. The results of this study showed an increase of isolates resistant to important drugs used in treatment of P. multocida infections in pigs, demonstrating the need for the implementation of rational use of antimicrobials in Brazilian swine industry.(AU)

Pasteurella (P.) multocida é o agente da pasteurelose pneumônica em suínos, a qual é comumente associada com o estágio final da pneumonia enzoótica suína ou complexo das doenças respiratórias dos suínos. Apesar de ser uma das doenças mais comuns e importantes na suinocultura, dados sobre suscetibilidade antimicrobiana de isolados de P. multocida são raros no Brasil. Dessa forma, o presente estudo foi realizado para determinar e comparar o perfil de suscetibilidade de isolados de P. multocida de suínos com lesões de pneumonia ou pleurite no Brasil durante dois períodos. Isolados históricos (período de 1981 a 1997; n=44) e contemporâneos (período de 2011 a 2012; n=50) foram usados para determinar a concentração inibitória mínima (CIM) de amoxicilina, enrofloxacina, florfenicol e tetraciclina através do teste de microdiluição em caldo. Florfenicol apresentou o menor nível de resistência para ambos os isolados históricos e contemporâneos (0% e 6%, respectivamente), enquanto que tetraciclina apresentou o maior nível de resistência (20.5% e 34%, respectivamente). Resistência a múltiplos antimicrobianos (amoxicilina, florfenicol e tetraciclina) foi observada em 6% dos isolados recentes. Foi observado aumento significativo (p˂0.05) na resistência a amoxicilina e enrofloxacina em isolados recentes comparado com isolados históricos (3.8% e 18%, respectivamente), provavelmente devido à pressão de seleção de antimicrobianos usados no tratamento e prevenção de infecções causadas por P. multocida. Os resultados deste trabalho demostraram o aumento de isolados resistentes a importantes drogas utilizadas no tratamento de infecções causadas por P. multocida em suínos, evidenciando a necessidade da implementação do uso racional de antimicrobianos na suinocultura brasileira.(AU)

Antimicrobial susceptibility profiles of Staphylococcus spp. from domestic and wild animals / Perfil de suscetibilidade antimicrobiana e diversidade de Staphylococcus spp. de animais domésticos e silvestres

The aim of this study was to determine the prevalence and diversity of veterinary clinical isolates of Staphylococcus and analyze their antimicrobial susceptibility. One hundred Staphylococcus spp. clinical isolates from domestic and wild animals were subjected to partial sequencing of the 16S rRNA gene to species determination. Antimicrobial susceptibility was obtained by a disk diffusion test against six antibiotics: amoxicillin (AMX), cephalexin (LEX), ciprofloxacin (CIP), erythromycin (ERY), gentamicin (GEN) and trimethoprim-sulfamethoxazole (SXT). The most common specie was S. pseudintermedius (61%, 61/100) and resistance to ERY (57%, 57/100), SXT (50%, 50/100) and AMX (46%, 46/100) was detected most frequently. In total, 40% (40/100) of Staphylococcus spp. exhibited a multidrug-resistant (MDR) phenotype. Results of this study emphasize that animals are reservoir of MDR Staphylococcus spp.

O objetivo do presente trabalho foi determinar a prevalência e diversidade de isolados clínicos veterinários de Staphylococcus e analisar o perfil de suscetibilidade a antimicrobianos. Um total de 100 Staphylococcus spp. isolados de amostras clínicas de animais domésticos e silvestres foram submetidos ao sequenciamento parcial do gene 16S rRNA, para determinação da espécie. A suscetibilidade antimicrobiana foi obtida por meio da técnica de Disco Difusão contra seis antibióticos: amoxicilina, cefalexina, ciprofloxacina, eritromicina, gentamicina e sulfazotrim. A espécie mais frequente foi S. pseudintermedius (61%, 61/100) e a resistência à eritromicina (57%, 57/100), Sulfazotrim (50%, 50/100) e Amoxicilina (46%, 46/100) foi detectada mais frequentemente. No total, 40% (40/100) dos Staphylococcus spp. demonstraram um fenótipo de multirresistência a drogas (MRD). Os resultados obtidos neste trabalho reforçam o fato de que animais são reservatórios de Staphylococcus spp. MRD.

Antimicrobial susceptibility profiles of Staphylococcus spp. from domestic and wild animals / Perfil de suscetibilidade antimicrobiana e diversidade de Staphylococcus spp. de animais domésticos e silvestres

The aim of this study was to determine the prevalence and diversity of veterinary clinical isolates of Staphylococcus and analyze their antimicrobial susceptibility. One hundred Staphylococcus spp. clinical isolates from domestic and wild animals were subjected to partial sequencing of the 16S rRNA gene to species determination. Antimicrobial susceptibility was obtained by a disk diffusion test against six antibiotics: amoxicillin (AMX), cephalexin (LEX), ciprofloxacin (CIP), erythromycin (ERY), gentamicin (GEN) and trimethoprim-sulfamethoxazole (SXT). The most common specie was S. pseudintermedius (61%, 61/100) and resistance to ERY (57%, 57/100), SXT (50%, 50/100) and AMX (46%, 46/100) was detected most frequently. In total, 40% (40/100) of Staphylococcus spp. exhibited a multidrug-resistant (MDR) phenotype. Results of this study emphasize that animals are reservoir of MDR Staphylococcus spp.(AU)

O objetivo do presente trabalho foi determinar a prevalência e diversidade de isolados clínicos veterinários de Staphylococcus e analisar o perfil de suscetibilidade a antimicrobianos. Um total de 100 Staphylococcus spp. isolados de amostras clínicas de animais domésticos e silvestres foram submetidos ao sequenciamento parcial do gene 16S rRNA, para determinação da espécie. A suscetibilidade antimicrobiana foi obtida por meio da técnica de Disco Difusão contra seis antibióticos: amoxicilina, cefalexina, ciprofloxacina, eritromicina, gentamicina e sulfazotrim. A espécie mais frequente foi S. pseudintermedius (61%, 61/100) e a resistência à eritromicina (57%, 57/100), Sulfazotrim (50%, 50/100) e Amoxicilina (46%, 46/100) foi detectada mais frequentemente. No total, 40% (40/100) dos Staphylococcus spp. demonstraram um fenótipo de multirresistência a drogas (MRD). Os resultados obtidos neste trabalho reforçam o fato de que animais são reservatórios de Staphylococcus spp. MRD.(AU)

Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates

Pan-drug resistant Gram-negative bacteria, being resistant to most available antibiotics, represent a huge threat to the medical community. Colistin is considered the last therapeutic option for patients in hospital settings. Thus, we were concerned in this study to demonstrate the membrane permeabilizing activity of colistin focusing on investigating its efficiency toward those pan-drug resistant isolates which represent a critical situation. We determined the killing dynamics of colistin against pan-drug resistant isolates. The permeability alteration was confirmed by different techniques as: leakage, electron microscopy and construction of an artificial membrane model; liposomes. Moreover, selectivity of colistin against microbial cells was also elucidated. Colistin was proved to be rapid bactericidal against pan-drug resistant isolates. It interacts with the outer bacterial membrane leading to deformation of its outline, pore formation, leakage of internal contents, cell lysis and finally death. Furthermore, variations in membrane composition of eukaryotic and microbial cells provide a key for colistin selectivity toward bacterial cells. Colistin selectively alters membrane permeability of pan-drug resistant isolates which leads to cell lysis. Colistin was proved to be an efficient last line treatment for pan-drug resistant infections which are hard to treat.(AU)

Flora bacteriana e perfil de sensibilidade microbiana em ouvido médio de cães da cidade de Viçosa, Alagoas / Bacterial flora and antimicrobial susceptibility profile in dog's meddle ears from Viçosa city, Alagoas

A otite resulta de qualquer inflamação do conduto auditivo, com numerosos agentes etiológicos envolvidos e diferentes fatores predisponentes, figurando dentre as infecções mais frequentes em cães, em qualquer faixa etária. Objetivou-se nesse estudo, identificar e comparar a frequência de agentes etiológicos da otite em cães domiciliados e errantes, bem como avaliar a susceptibilidade a antimicrobianos utilizados na clínica veterinária. As colheitas foram realizadas no município de Viçosa, Alagoas, com o auxílio de swabs esterelizados, na região média dos dois ouvidos de cada animal, sendo 10 cães errantes e 10 cães domiciliados, totalizando 40 amostras, as quais foram submetidas a exame direto e microbiológico. As bactérias isoladas foram submetidas ao teste de sensibilidade microbiana in vitro, utilizando o método de difusão com discos antimicrobianos de: Cefalexina (30ug), Eritromicina (15ug), Tobramicina (10ug), Azitromicina (15ug) e Sulfazotrin (25ug). No exame microbiológico foram identificados Staphylococcus sp., Streptococcus sp., Bacillus sp. e Malassezia sp., e a frequência de animais domiciliados positivos neste mesmo exame foi de 50% (5/10), enquanto nos errantes foi de 70% (7/10). A incidência de agentes patogênicos da otite em cães errantes supera a de cães domiciliados por estes estarem sujeitos a várias en- fermidades e supressões do sistema imunológico, que são fatores primários para a otite. Nos cães domiciliados, 60% (3/5) apresentaram agentes, sendo estes Staphylococcus sp. e Bacillus sp., resistentes a todos os antimicrobianos, tendo os outros 40% (2/5) Sta- phylococcus sp.com susceptibilidade intermediária somente ao Cefalexina. Já nos cães errantes, 85,72% (6/7) apresentaram agentes, sendo estes Staphylococcus sp., Steptococcus sp. e Bacillus sp., resistentes a todos os antimicrobianos, enquanto 14,28% (1/7) também apresentaram Staphylococcus sp. com susceptibilidade intermediária somente a Cefalexina, sendo este antibiótico, portanto, o mais eficaz desse estudo. A maior frequência de bactérias resistentes em cães errantes pode ser justificada pelo fato destes se infectarem e as propagarem entre si, uma vez que os microrganismos resistentes podem passar os genes da resistência à sua descendência, onde as bactérias que transferem ou recebem estes genes podem ser até mesmo de gêneros diferentes. Nos animais do- miciliados a frequência de bactérias resistentes foi menor, porém, a multirresistência aos antibióticos evidencia a importância do controle do uso de antibióticos, bem como o uso de exames laboratoriais para a avaliação da susceptibilidade a antimicrobianos pelo médico veterinário, a fim de obter maior sucesso na cura e diminuir a seleção de microrganismos resistente.

Isolation, enumeration, molecular identification and probiotic potential evaluation of lactic acid bacteria isolated from sheep milk

Lactic acid bacteria species were molecularly identified in milk from Lacaune, Santa Inês and crossbred sheep breeds and their in vitro probiotic potential was evaluated. The species identified were Enterococcus faecium (56.25%), E. durans (31.25%) and E. casseliflavus (12.5%). No other lactic acid bacteria species, such as lactobacilli, was identified. Most of the isolated enterococci were resistant to gastric pH (2.0) and to 0.3% oxgall. All tested enterococci were resistant to ceftazidime, oxacillin and streptomycin and sensible to clindamycin, erythromycin and penicillin. The resistance to ciprofloxacin, gentamicin, tetracycline and vancomycin varied among tested species. All tested enterococci strongly inhibited (P<0.05) Escherichia coli and Listeria monocytogenes, moderately inhibited E. faecalis and Staphylococcus aureus and did not inhibit Pseudomonas aeruginosa, Salmonella enterica var. Typhimurium and also one E. durans sample isolated from sheep milk. Four samples of E. faecium, one of E. durans and one of E. casseliflavus presented the best probiotic potential.(AU)

Espécies de bactérias ácido-lácticas foram identificadas em nível molecular em leite das raças ovinas Lacaune, Santa Inês e suas mestiças, e o seu potencial probiótico in vitro foi avaliado. As espécies identificadas foram Enterococcus faecium (56,25%), E. durans (31,25%) e E. casseliflavus (12,5%). Nenhuma outra espécie de bactéria ácido-láctica, como Lactobacillus sp., foi identificada. A maioria dos enterococos isolados foi resistente ao pH gástrico (2.0) e a 0,3% de oxgall. Todos os enterococos testados foram resistentes à ceftazidima, oxacilina e estreptomicina e sensíveis à clindamicina, eritromicina e penicilina. A resistência à ciprofloxacina, gentamicina, tetraciclina e vancomicina variou entre as amostras. Todos os enterococos testados inibiram fortemente (P<0,05) Escherichia coli e Listeria monocytogenes, inibiram moderadamente E. faecalis e Staphylococcus aureus e não inibiram Pseudomonas aeruginosa, Salmonella enterica var. Typhimurium e uma amostra de E. durans isolada de leite de ovelha. Quatro amostras de E. faecium, uma de E. durans e uma de E. casseliflavus apresentaram o melhor potencial probiótico.(AU)

Virulence factors, antimicrobial resistance, and plasmid content of Escherichia coli isolated in swine commercial farms / Fatores de virulência, resistência aos antimicrobianos, presença de plasmídeos em Escherichia coli isoladas de amostras clínicas e ambientais de suínos

Virulence factors and antimicrobial resistance patterns of Escherichia coli isolates were evaluated. A total of 80 E. coli isolates were evaluated, being 64 from clinical samples (intestinal content and fragments of organs from diarrheic piglets), seven from feces of clinically healthy piglets and sows, and nine environmental samples (five from facilities, two from feed, one from insect, and one from waste). Molecular characterization was performed by PCR detection of fimbriae and toxin genes and plasmid content determination. The isolates were also characterized according to their resistance or sensitivity to the following drugs: ampicillin, trimethoprim:sulfamethoxazole, tetracycline, amikacine, colistin, norfloxacin, florfenicol, enrofloxacin, cefalexin, trimethoprim, neomycin, chloramphenicol, and gentamicin. From 80 E. coli isolates, 53.8 percent were classified as enterotoxigenic E. coli (ETEC), 2.5 percent were shiga toxin-producing E. coli (STEC), and 43.8 percent showed a non specific pattern and were unclassified. One fecal isolate from non-diarrheic piglet was classified as ETEC by PCR. Clinical isolates showed resistance mainly for tetracycline and trimethoprim:sulfamethoxazole. Plasmidial DNA was observed in 70 isolates, being 78.5 percent of clinical isolates, 8.57 percent of non-diarrheic feces, and 12.8 percent of environment.(AU)

Os fatores de virulência e a resistência aos antimicrobianos foram avaliados em Escherichia coli. Um total de 80 isolados de E. coli, sendo 64 de amostras clínicas (conteúdo intestinal e fragmentos de órgãos de leitões diarreicos), sete das fezes de porcas e leitões saudáveis e nove de amostras ambientais (cinco de instalações, dois de alimentos, um de inseto e um de esterqueira). A caracterização molecular feita pela PCR objetivou detectar fimbrias e toxinas, bem como a determinação do conteúdo de plasmídeos. Os isolados foram caracterizados quanto à resistência ou sensibilidade às seguintes drogas: ampicilina, sulfazotrim, tetraciclina, amikacina, colistina, norfloxacina, florfenicol, enrofloxacina, cefalexina, trimetoprim, neomicina, cloranfenicol e gentamicina. Dos 80 isolados, 53,8 por cento foram classificados como E. coli enterotoxigênica (ETEC), 2,5 por cento como E. coli produtora de shiga toxina (STEC) e 43,8 por cento, por não apresentarem padrão específico, não foram classificadas. Pela PCR, um isolado de fezes de suíno sem diarreia foi classificado como ETEC. Os isolados das amostras clínicas foram principalmente resistentes à tetraciclina e à sulfazotrim. Em 70 isolados, observaram-se DNA plasmidial, destes 78,5 por cento foram obtidos de amostras clínicas, 8,57 por cento de leitões sadios e 12,8 por cento de amostras ambientais.(AU)

Suscetibilidade à azitromicina de agentes bacterianos isolados de processos infecciosos em diferentes sítios de animais de companhia / Azithromycin susceptibility pattern of bacterial isolated from different sites of infections in pet animals

Avaliou-se o perfil de suscetibilidade bacteriana de diferentes sítios infecciosos frente aos antimicrobianos de eleição e determinaram-se o perfil de atividade in vitro e a concentração inibitória mínima (CIM) da azitromicina. Diferentes testes fenotípicos detectaram resistência à azitromicina em 45 por cento de Staphylococcus spp. e 65 por cento dos bastonetes Gram-negativo. A CIM50 para S. aureus foi 4,0μg/mL para S. intermedius 1,0μg/mL, Staphylococcus spp. coagulase-negativo >512μg/mL e bastonetes Gram-negativo 256μg/mL. Investigou-se, também, uma possível resistência cruzada entre oxacilina e azitromicina por meio da detecção do gene mecA em Staphylococcus spp. Foi possível detectar resistência à azitromicina em nove (15 por cento) isolados de Staphylococcus spp. mecA positivo.(AU)

Antimicrobials susceptibility pattern of bacterial isolated from different sites of infection, in vitro azithromycin activity pattern, and its minimum inhibitory concentration (MIC) values were evaluated. Different phenotypic tests detected azithromycin resistance in 45 percent of Staphylococcus spp. and 65 percent of resistant Gram-negative rods. MIC50 was 4.0μg/mL for Staphylococcus aureus, 1.0μg/mL for S. intermedius, >512.0μg/mL for coagulase negative Staphylococcus, and 256.0μg/mL for Gram-negative rods. In addition, it was investigated the possible cross-resistance between oxacillin and azithromycin, by detection of mecA gen in Staphylococcus spp. Nine (15 percent) mecA-positive Staphylococcus spp. were also phenotypically resistant to azithromycin.(AU)

Multirresistência antimicrobiana em cepas de Escherichia coli isoladas de cadelas com piometra / Antimicrobial multi-resistance of Escherichia coli strains isolated from bitches with pyometra

The antimicrobial sensibility of Escherichia coli strains isolated from the uterine content of bitches was evaluated. Fifteen E. coli strains were tested in relation to their susceptibility to different antimicrobials. The results demonstrated 100 percent of resistance to all tested drugs, being a quite conflicting finding compared to other works, which observed variable resistance of those bacteria to different antimicrobials but not the same multi-resistance pattern. The detection of those multi-resistance strains configures a problem, with important implications on the antimicrobial therapy. Therefore, additional investigations for a best characterization and extension of this problem are needed.(AU)

Utilização indiscriminada de antimicrobianos e sua contribuição a multirresitência bacteriana / The abuse of antimicrobials drugs and the appearance of resistance

Os antimicrobianos são amplamente utilizados na clínica veterinária e o uso indiscriminado destas drogas contribui com o aumento progressivo da resistência bacteriana. A resistência aos antibióticos é um sério problema do ponto de vista clínico e de saúde pública, devido ao tratamento dos animais tomar seus produtos e derivados fonte para resistência bacteriana na espécie humana. A origem da resistência pode ser genética ou não e independente de qual seja a forma de maior importância neste processo, o fato é que o número de novas bactérias resistentes e patogênicas para os animais e humanos cresce mais rápido do que a capacidade dos laboratórios e indústrias produzirem novas drogas.(AU)

Antibiotics are used widely in veterinary medicine and theindiscriminate use of these drugs contributes with the gradual increase of the bacterial resistance. The resistance to antibiotics is a seriousproblem of public health because of man use products andderivatives source from treated animals. The origin of the resistancecan be genetic or not. Today the number of bacteria have becomeresistant to pharmaceutical antibiotics in veterinary medicine andhuman medicine beings grows more faster than the new drugswhich are developing in the pharmaceutical industry. (AU)